What is 908 Devices Inc?
, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.
MASS · Verdict
Solid reward · moderate risk
MASS stands out on balance sheet and volatility, but watch the profitability signal.
Based on 88% data coverage
MASS · Verdict
Current ratio 4.10
Top decile vs peers
Rev +12.2% CAGR · earnings +48.2%
Above average
-121% net margin · -54% ROE
-52% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as process fingerprint data to support large-scale efforts in predictive bioprocess modeling. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 246.84M.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.